BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg. 2003;237:201-207. [PMID: 12560778 DOI: 10.1097/01.sla.0000048446.18118.fc] [Cited by in Crossref: 22] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Soares KC, Jarnagin WR. The Landmark Series: Hilar Cholangiocarcinoma. Ann Surg Oncol 2021;28:4158-70. [PMID: 33829358 DOI: 10.1245/s10434-021-09871-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Li J, Zhou MH, Ma WJ, Li FY, Deng YL. Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring? World J Gastroenterol 2020; 26(24): 3318-3325 [PMID: 32655260 DOI: 10.3748/wjg.v26.i24.3318] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
3 Kovalenko YA, Zharikov YO. [Portal cholangiocarcinoma: epidemiology, staging principles and aspects of tumor biology]. Khirurgiia (Mosk) 2017;:85-91. [PMID: 29186104 DOI: 10.17116/hirurgia20171185-91] [Reference Citation Analysis]
4 Shah SH, Gupta N, Gupta G, Mehta A, Singh S. Lymph node micrometastasis in gallbladder cancer. Indian J Gastroenterol 2017;36:268-74. [PMID: 28782079 DOI: 10.1007/s12664-017-0775-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Gu J, Xia L, Xu B, Lu T, Halmurat O, Wang J, Zhang J, Ding Y, Xia Q. Clinical prognostic significance of regional and extended lymphadenectomy for biliary cancer with para-aortic lymph node metastasis: A systematic review and meta-analysis. Dig Liver Dis 2016;48:717-25. [PMID: 27094254 DOI: 10.1016/j.dld.2016.03.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Mantel HT, Wiggers JK, Verheij J, Doff JJ, Sieders E, van Gulik TM, Gouw AS, Porte RJ. Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma. Ann Surg Oncol. 2015;22 Suppl 3:S1107-S1115. [PMID: 26178761 DOI: 10.1245/s10434-015-4723-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
7 Morimoto J, Tanaka H, Ohira M, Kubo N, Muguruma K, Sakurai K, Yamashita Y, Maeda K, Sawada T, Hirakawa K. The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer. Dis Esophagus 2014;27:63-71. [PMID: 23480452 DOI: 10.1111/dote.12043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Zhimin G, Noor H, Jian-Bo Z, Lin W, Jha RK. Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit. 2013;19:648-656. [PMID: 23921971 DOI: 10.12659/msm.889379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
9 Nimura Y. In response to the article of Dr. Nadia Peparini, “Extended lymphadenectomy does not improve prognosis in pancreatic carcinoma: is that really so?”. Journal of Hepato-Biliary-Pancreatic Sciences 2012;19:299-299. [DOI: 10.1007/s00534-011-0502-6] [Reference Citation Analysis]
10 Lee SE, Jang JY, Kim MA, Kim SW. Clinical implications of immunohistochemically demonstrated lymph node micrometastasis in resectable pancreatic cancer. J Korean Med Sci 2011;26:881-5. [PMID: 21738340 DOI: 10.3346/jkms.2011.26.7.881] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
11 Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10:190-5. [PMID: 18773053 DOI: 10.1080/13651820801992575] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
12 Witzigmann H, Lang H, Lauer H. Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) 2008;10:154-60. [PMID: 18773044 DOI: 10.1080/13651820801992567] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
13 Wu Y, Johlin FC, Rayhill SC, Jensen CS, Xie J, Cohen MB, Mitros FA. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 2008;14:279-86. [PMID: 18306329 DOI: 10.1002/lt.21287] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
14 Lang H, Kaiser GM, Zöpf T, Sotiropoulos GC, Frilling A, Malagó M, Broelsch CE. [Surgical therapy of hilar cholangiocarcinoma]. Chirurg 2006;77:325-34. [PMID: 16568258 DOI: 10.1007/s00104-006-1177-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
15 Witzigmann H, Berr F, Ringel U, Caca K, Uhlmann D, Schoppmeyer K, Tannapfel A, Wittekind C, Mossner J, Hauss J, Wiedmann M. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg. 2006;244:230-239. [PMID: 16858185 DOI: 10.1097/01.sla.0000217639.10331.47] [Cited by in Crossref: 219] [Cited by in F6Publishing: 238] [Article Influence: 12.9] [Reference Citation Analysis]
16 Sasaki E, Nagino M, Ebata T, Oda K, Arai T, Nishio H, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg. 2006;244:99-105. [PMID: 16794394 DOI: 10.1097/01.sla.0000217675.22495.6f] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.1] [Reference Citation Analysis]
17 Taniguchi K, Iida T, Hori T, Yagi S, Imai H, Shiraishi T, Uemoto S. Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol 2006; 12(16): 2549-2555 [PMID: 16688800 DOI: 10.3748/wjg.v12.i16.2549] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kazama S, Watanabe T, Ajioka Y, Kanazawa T, Nagawa H. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer. 2006;94:293-298. [PMID: 16404429 DOI: 10.1038/sj.bjc.6602927] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 4.8] [Reference Citation Analysis]
19 Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the Nagoya experience. HPB (Oxford) 2005;7:259-62. [PMID: 18333203 DOI: 10.1080/13651820500373010] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 4.7] [Reference Citation Analysis]
20 Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hänninen E, Hintze RE. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality. Langenbecks Arch Surg. 2003;388:194-200. [PMID: 12819970 DOI: 10.1007/s00423-003-0383-5] [Cited by in Crossref: 126] [Cited by in F6Publishing: 132] [Article Influence: 6.3] [Reference Citation Analysis]